【PharmaEssentia】February 2026 Revenue Reaches 1.60 Billion (YoY +56.7%)
NQ Score
67/100
N1 Content Completeness
4
AI Summary (NQ-processed)
PharmaEssentia, a new drug development company, announced that its revenue for February 2026 reached 1.60 billion, a year-over-year increase of 56.7%. This strong performance is primarily attributed to the sales of its new drug for treating polycythemia vera, highlighting its success in the biotechnology and healthcare market.
AI analysis data is not yet available.